Daniel Meuser of Pennsylvania’s 9th district partially sells NVIDIA stock

Rep. Daniel Meuser partially sold NVIDIA shares on Feb 25, 2026 (reported Mar 9, 2026) in a trade valued between $1,001 and $15,000 from a Schwab brokerage account. The article highlights NVIDIA’s strong performance — an 88% one-year return and revenue up 65% to $216 billion — and InvestingPro’s view that NVDA trades below its fair value as a ‘Most Undervalued’ stock. The disclosure is routine and small in size, unlikely to move the stock materially but noted for transparency given the congressional ownership. Investors should treat the transaction as informational rather than a signal of company fundamentals.

Analysis

The market attention here is a signal-of-noise more than a directional catalyst — the measurable drivers for NVDA’s next leg are order cadence from hyperscalers, export-control trajectories, and near-term options/gamma structure rather than incremental retail headlines. Expect meaningful intramonth swings driven by options expiries and earnings windows; gamma pinning can amplify a 10-20% move in days, then reverse as dealers rebalance.

Second-order winners from sustained NVDA strength are capital goods and lithography suppliers (equipment vendors and specialty contractors) and high-bandwidth-memory suppliers; losers in a demand drawdown are turnkey server builders and commodity memory names with thin pricing power. A pause or 2-quarter slowdown in hyperscaler bookings would transmit quickly through OEM backlog models and could compress consensus multiples by ~25-35% within 6-12 months.

Key tail risks: (1) renewed, stricter export controls to China that shave 10-25% off near-term addressable market; (2) hyperscaler capex digestion leading to a 2-3 quarter order trough; and (3) volatility spikes around earnings that reprice IV and force deleveraging. Near-term catalysts to watch are public cloud capex commentary over the next two earnings cycles and any regulatory headlines out of US/China in the coming 1-3 months.

From a positioning perspective, carry and optionality matter more than outright conviction: use structured, financed long exposure (long-dated calls funded by short-term call sales) or small, hedged share positions rather than naked directional bets. If the market misprices cyclical risk, relative-value opportunities (long NVDA vs more cyclic server names) will outperform outright long or short across the 3–12 month horizon.

Key Decisions for Investors

• Core position (2–4% NAV): Buy NVDA via Jan-2027 LEAPs sized to equal 2% NAV exposure, funded by selling 8–12 week calls (1–2x notional). Rationale: captures multi-year AI upside while monetizing high near-term IV; target 12–24 month return 40–100% vs premium at risk if secular demand disappoints.
• Tactical pullback buy (1–2% NAV): Add shares if NVDA gaps down 10–15% on headline/noise within the next 4 weeks. Set tactical stop-loss at 20% and target a 30–60% upside over 6–12 months; this preserves capital if a capex trough emerges.
• Relative-value pair (net 0.5–1% NAV long): Long NVDA / short SMCI — equal notional size over 6–9 months to isolate platform/IP strength vs cyclical server build exposure. Payoff: if NVDA outperforms by 15–30% relative, the trade nets positive; risk is correlated upside for both if a broad AI spending wave accelerates.
• Short-term hedge (0.5% NAV cost): Buy a 3–6 month put spread on NVDA to protect ~15–25% downside ahead of the next earnings/capex commentary. Cost should be contained (~3–6% of the hedged position) and preserves upside while capping drawdown risk.